"This isn't about you," Rep. Alexandria Ocasio-Cortez (D-NY) told Gilead CEO Daniel O'Day. "We have legislated a system that allows [this] to happen."
Activists say this relatively small giveaway won't advance PrEP access or help end HIV in the U.S. the way a true price reduction would.
But a survey reveals that about a third of black and Latino gay men would be willing to pay more than $50 per month for a prescription.
In a debate during a plenary session, Michael Saag, M.D., argued for more activism to make PrEP accessible to people who need it.
The director of the U.S. National Institutes of Health talks about a newly published expert article explaining that sexual transmission of HIV can't happen if a person is on fully effective treatment.
"PrEP must not be cast as the lone villain in the syphilis crisis, nor MSM engaging in chemsex cast as debauched vectors of transmission."
As part of comprehensive efforts to reduce the number of new HIV infections, some states are innovating to make HIV pre-exposure prophylaxis (PrEP) more accessible to individuals at high risk of HIV.
On Nov. 20, 2018, the U.S. Preventive Services Task Force released a draft recommendation that could transform HIV-1 pre-exposure prophylaxis (PrEP) scale-up in the United States.